Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.

CONCLUSION: This analysis suggests that secukinumab can benefit people with PsA across the clinical phenotypic spectrum commonly encountered in this disease.
PMID: 31615919 [PubMed - as supplied by publisher]

Source: J Rheumatol - October 14, 2019 Category: Rheumatology Authors: Orbai AM, McInnes IB, Coates LC, Husni ME, Gladman DD, Gossec L, Pricop L, Chambenoit O, Meng X, Mease PJ Tags: J Rheumatol Source Type: research